Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan. (Q52861703)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 2016

Language	Label	Description	Also known as
English	Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan.	scientific article published in July 2016

Statements

scholarly article

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/27365141

Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan. (English)

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/27365141

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Miyuki Sugimoto

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Shoko Ito

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Kento Umino

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Daisuke Minakata

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Hirofumi Nakano

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Ryoko Yamasaki

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Yasufumi Kawasaki

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Masahiro Ashizawa

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Chihiro Yamamoto

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Shin-Ichiro Fujiwara

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Kiyoshi Okazuka

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Kaoru Hatano

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Kazuya Sato

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Iekuni Oh

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Ken Ohmine

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Takahiro Suzuki

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Kazuo Muroi

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Shinichi Kako

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Yoshinobu Kanda

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

1 July 2016

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/27365141

Annals of Hematology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

95

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1513-1519

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

The evolving role of stem cell transplants in lymphomas

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2740-9

21 January 2018

Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2740-9

21 January 2018

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2740-9

21 January 2018

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2740-9

21 January 2018

Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2740-9

21 January 2018

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2740-9

21 January 2018

Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2740-9

21 January 2018

BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: a single center comparative analysis of efficacy and toxicity.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2740-9

21 January 2018

Safety and efficacy of high-dose ranimustine, cytarabine, etoposide and CY (MCVAC) regimen followed by autologous peripheral blood stem cell transplantation for high-risk diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2740-9

21 January 2018

Decitabine as a conditioning regimen in haploidentical stem cell transplantation for refractory acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2740-9

21 January 2018

Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus and varicella zoster virus diseases after autologous hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2740-9

21 January 2018

Investigation of the freely available easy-to-use software 'EZR' for medical statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2740-9

21 January 2018

Comparison of 1-day vs 2-day dosing of high-dose melphalan followed by autologous hematopoietic cell transplantation in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2740-9

21 January 2018

Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2740-9

21 January 2018

BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS00277-016-2740-9

21 January 2018

Identifiers

10.1007/S00277-016-2740-9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27365141%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52861703&oldid=1203335378"